These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6261269)
1. Correlation between the dose and development of acute tolerance to the hypothermic effect of THC. Uran B; Tulunay FC; Ayhan IH; Ulkü E; Kaymakçalan S Pharmacology; 1980; 21(6):391-5. PubMed ID: 6261269 [TBL] [Abstract][Full Text] [Related]
2. Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats. Nguyen JD; Grant Y; Kerr TM; Gutierrez A; Cole M; Taffe MA Pharmacol Biochem Behav; 2018 Sep; 172():33-38. PubMed ID: 30031028 [TBL] [Abstract][Full Text] [Related]
3. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse. Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949 [TBL] [Abstract][Full Text] [Related]
4. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner. Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728 [TBL] [Abstract][Full Text] [Related]
5. Explication of CB Nguyen JD; Creehan KM; Grant Y; Vandewater SA; Kerr TM; Taffe MA Drug Alcohol Depend; 2020 Sep; 214():108166. PubMed ID: 32717503 [TBL] [Abstract][Full Text] [Related]
6. Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice. Thorat SN; Bhargava HN Brain Res; 1994 Dec; 667(1):77-82. PubMed ID: 7534610 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats. Wiley JL; O'connell MM; Tokarz ME; Wright MJ J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531 [TBL] [Abstract][Full Text] [Related]
8. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol. Pertwee RG Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752 [TBL] [Abstract][Full Text] [Related]
9. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice. Watanabe K; Yamamoto I; Yoshimura H Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407 [TBL] [Abstract][Full Text] [Related]
10. Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Malone DT; Taylor DA Br J Pharmacol; 1998 Aug; 124(7):1419-24. PubMed ID: 9723953 [TBL] [Abstract][Full Text] [Related]
11. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Paronis CA; Nikas SP; Shukla VG; Makriyannis A Behav Pharmacol; 2012 Dec; 23(8):802-5. PubMed ID: 23075707 [TBL] [Abstract][Full Text] [Related]
12. Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice. Chopda GR; Parge V; Thakur GA; Gatley SJ; Makriyannis A; Paronis CA J Pharmacol Exp Ther; 2016 Aug; 358(2):334-41. PubMed ID: 27231154 [TBL] [Abstract][Full Text] [Related]
13. Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region. Schmeling WT; Hosko MJ Pharmacol Biochem Behav; 1976 Jul; 5(1):79-83. PubMed ID: 996043 [TBL] [Abstract][Full Text] [Related]
14. Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex. Moore CF; Davis CM; Harvey EL; Taffe MA; Weerts EM Pharmacol Biochem Behav; 2021 Mar; 202():173116. PubMed ID: 33493547 [TBL] [Abstract][Full Text] [Related]
15. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity. Anderson PF; Jackson DM; Chesher GB; Malor R Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992 [TBL] [Abstract][Full Text] [Related]
16. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats. Li DM Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124 [TBL] [Abstract][Full Text] [Related]
17. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats. Taffe MA; Creehan KM; Vandewater SA Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111 [TBL] [Abstract][Full Text] [Related]
19. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol. Fitton AG; Pertwee RG Br J Pharmacol; 1982 Feb; 75(2):409-14. PubMed ID: 6313110 [TBL] [Abstract][Full Text] [Related]
20. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice. Davies JA; Graham JD Psychopharmacology (Berl); 1980; 69(3):299-305. PubMed ID: 6251505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]